As an organization founded by a family for families, The Leukemia & Lymphoma Society (LLS) is celebrating 70 years of impact on generations of families, researchers and volunteers while looking to the future by redoubling its commitment to improve treatments and care for children with cancer. To accomplish its bold vision for children, LLS is launching The LLS Children’s Initiative to deliver cures and care for children by disrupting drug development for pediatric cancers and ex...
Check out our June education events and see if LLS is coming to a city near you! Beyond Blood Cancer – New Advancements and Support June 2, 2019 – Waltham, MA https://www.eiseverywhere.com/392459 Cancer Survivorship: Living Through & Beyond Blood Cancer June 5, 2019 – Vero Beach, FL https://www.eiseverywhere.com/426989 Supervivencia: Viviendo través y más allá del cáncer (Spanish program) June 11, 2019 – El Paso, TX https://www.eiseverywhere.com/451578 Update...
They came from California, Colorado and Arizona, North Dakota, New Hampshire, Texas, Louisiana and Minnesota, each with their own story to tell. In all, 36 volunteers representing 25 states came to Washington D.C. this week to learn how to effectively use their stories to advocate for policies to protect blood cancer patients’ access to treatment and care. For three days these patients, survivors and caregivers took part in a training session with the dedicated policy and advocacy staff...
In recent years, there has been a rapid surge in the amount of genomic information available to researchers. This information enhances the understanding of human disease and provides the fuel needed to achieve personalized medicine. New advances in technology and in the ability to analyze massive datasets have allowed scientists to more precisely define cancer behavior, including how these diseases adapt to evade therapy. In order to survive, cancer cells undergo genetic changes in their DNA ...
The steady pace of progress in treating patients with acute myeloid leukemia (AML), still one of the most deadly blood cancers, continued with today’s U.S. Food & Drug Administration’s second approval of a drug called ivosidenib (Tibsovo) that works for patients with a specific subtype of AML. In another win for precision medicine, where therapies are matched to a patient’s specific genetic profile, the FDA approved ivosidenib for newly diagnosed patients 75-years-of-age and ...
LLS may be coming to your town! Check out the list below of our free education programs. Rocky Mountain Blood Cancer Conference May 4, 2019 – Aurora, CO http://www.etouches.com/rmbcc19 Surviving Cancer: A Multidisciplinary Approach May 4, 2019 – Augusta, GA https://tinyurl.com/y4k978gh Exploring the Role of Transplant in Blood Cancer Treatment May 6, 2019 – Bethesda, MD https://www.eiseverywhere.com/418596 Living Well with CLL: diagnosis, treatment and ...
Myeloma Clinical Trial Participation: The Basics April 4, 2019 – Portland, OR https://www.eiseverywhere.com/407107 Living Well with CLL: diagnosis, treatment and support April 10, 2019 – Erie, PA https://bit.ly/CLLApril10 DC Metro Blood Cancer Conference April 13, 2019 – Washington, DC www.etouches.com/dcbcc19 Treatments and Survivorship in Blood Cancer Patients April 13, 2019 – Sioux Falls, SD https://www.eiseverywhere.com/402967 New and Eme...
Southern California Blood Cancer Conference March 2, 2019 – Anaheim, CA www.etouches.com/scabcc19 Surviving & Thriving with Blood Cancer March 2, 2019 – Cincinnati, OH https://www.eiseverywhere.com/400245 Living Well with CLL: diagnosis, treatment and support March 6, 2019 – Jericho, NY https://www.eiseverywhere.com/398155 Living Well with CLL: diagnosis, treatment and support March 21, 2019 – Fort Worth, TX https://www.eiseverywhere.com/401680 ...
Hey LLS Community! We are bringing several free education events to U.S. cities this month. Check out the list below to see if LLS is coming to you! February 2019 – Patient Education Programs Lonestar Blood Cancer Patient Education Summit February 9, 2019 – Dallas, TX https://www.lls.org/events/lonestar-blood-cancer-patient-education-summit *Please note: Registration is full! If you would like to be placed on the Wait List, please contact Dawn Guerrero at 972.996.5905 or da...
Join Alicia and Lizette from The Leukemia and Lymphoma Society as they speak with Dr. Ann LaCasce, Program Director of the Dana-Farber/ Partners CancerCare Fellowship, the largest hematology/oncology training program in the country. On this episode, Dr. LaCasce explains the difference between chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), CLL and its connection with Agent Orange exposure, resources available for Veterans, current and emerging therapies, clinical tria...
